CRISPR, EXZACT technologies boost gene-editing efficiency in plants from 1% to 90%

Screen Shot at PM

The perfect seed doesn’t exist—but can it? Breeders have tried without success for decades to perfectly combine yield, disease tolerance and weather hardiness to hit the Holy Grail. Now scientists say gene editing could be the key to success.

“This new technology allows us to discover, develop, deploy and commercialize traits with more precision and predictability,” says Steve Webb, Dow AgroSciences external technology and intellectual property portfolio development leader. “We see gene editing as rounding out the toolbox.”

Dow’s new gene-editing tool called EXZACT, co-developed by Sangimo Technologies, uses protein-based gene recognition. It promises faster, more accurate gene changes with less “collateral damage” than found in traditional breeding. Monsanto recently entered an agreement with Dow for access to the technology. “EXZACT is specific and recognizes larger gene sequences,” Webb adds.

Another tool, CRISPR-Cas9, uses nucleotide technology to provide highly specific gene alterations.

“CRISPR-Cas9 uses guide RNA to go inside cells and target a specific area in the genome,” says Paul Dabrowski, Synthego CEO. Synthego provides various gene-editing solutions, with CRISPR-Cas9 among the most popular. CRISPR-Cas9 allows breeders to change the genome down to a single gene they can delete, move, alter or replace.

…

“Before CRISPR, you might expect 1% to 5% of cells you’re modifying to be done correctly,” Dabrowski says. “With CRISPR and our products, we’ve brought it up to 80% to 90%.”

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post: Ctrl, Alt, Delete to Better Yields

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
ChatGPT-Image-Sep-23-2026-02_36_39-PM
Viewpoint: After firing the entire National Science Board, Trump reshapes funding initiatives. Here’s the good and the bad.
ChatGPT-Image-Sep-10-2026-10_36_07-AM
Viewpoint: Even lousy scientific articles can shield authors when they hype dubious health claims and products
generated-1790707585414
Facts & Fallacies podcast: America's health care system is broken. A doctor explains how to fix it
ChatGPT-Image-Sep-21-2026-03_15_09-PM
Viewpoint: Chipotle-inspired lesson: 10,000 sick customers suggest that processed foods can be safer than fresh ones
ChatGPT-Image-Sep-21-2026-11_54_00-AM
Viewpoint: Activist environmental NGOs are turning from public funding to activist billionaires to support their campaigns. It won’t end well.
Screenshot 2026-08-12 at 1.22
Activists vs. Scientists: Could “Butterfly Effect” fears derail gene-drive research targeting the flesh-eating screwworm?
Screenshot-2026-09-16-at-10.27.33-AM
Viewpoint: SCOTUS poised to address First Amendment tension between mandatory vaccines, children’s health and religious freedom 
sorghum farmers in kenya FARMERS TREND
Here are all the ways CRISPR gene editing is transforming Africa’s staple crops—and there’s a lot more innovation to come
ChatGPT-Image-Sep-22-2026-11_17_31-AM
The exploding controversy over AI’s built-in survival drive
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.